Australia markets closed

Corbus Pharmaceuticals Holdings Inc (3371.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
46.80-3.20 (-6.40%)
At close: 08:08PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
881.705
3,937
Operating expenses
Research development
23,541
31,168
16,137
36,445
98,267
Selling general and administrative
13,862
13,910
18,699
20,425
28,480
Total operating expenses
37,403
45,077
34,835
56,871
126,747
Operating income or loss
-37,403
-45,077
-34,835
-55,989
-122,810
Total other income/expenses net
6,069
3,398
-5,379
12,179
12,569
Income before tax
-33,757
-44,603
-42,347
-45,640
-111,269
Income from continuing operations
-33,757
-44,603
-42,347
-45,640
-111,269
Net income
-33,757
-44,603
-42,347
-45,640
-111,269
Net income available to common shareholders
-33,757
-44,603
-42,347
-45,640
-111,269
Basic EPS
-11.12
-10.31
-10.15
-11.10
-42.60
Diluted EPS
-11.12
-10.31
-10.15
-11.10
-42.60
Basic average shares
4,264
4,328
4,171
4,100
2,604
Diluted average shares
4,264
4,328
4,171
4,100
2,604